Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
07/2005
07/28/2005WO2005040105B1 Novel surfactants and applications thereof
07/28/2005US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor
07/28/2005US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase
07/28/2005US20050165069 Statine derivatives for the treatment of Alzheimer's disease
07/28/2005US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/28/2005US20050164872 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
07/28/2005DE10359636A1 Verfahren zur Abtrennung von Methylmercaptan aus Reaktionsgemischen Process for the separation of methyl mercaptan from reaction mixtures
07/27/2005EP1556344A1 Treating syndrome x with substituted tetralins and indanes
07/27/2005EP1556343A1 Process for the production of 3-methylthiopropanal
07/27/2005EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases
07/27/2005CN1646488A Substituted aryl ketones
07/27/2005CN1646478A 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
07/27/2005CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles
07/27/2005CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them
07/26/2005US6921840 SPECT imaging agents for serotonin transporters
07/26/2005US6921823 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
07/26/2005US6921777 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses
07/26/2005CA2234642C 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
07/26/2005CA2133439C Compounds useful for treating allergic and inflammatory diseases
07/21/2005WO2005042478A3 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
07/21/2005US20050159612 Such as 1-dodecane-thiotrifluoroacetate; alkyl/arylthiol is treated with trifluoroacetic anhydride in presence of pyridine, solvent (dichloromethane), and dimethylaminopyridine (DMAP) as catalyst; for protection of amino acids
07/21/2005US20050159459 inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful to reduce forming beta peptides
07/21/2005US20050159427 N-acylsulfonamide apoptosis promoters
07/21/2005US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
07/21/2005US20050159314 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent
07/20/2005EP1555313A2 Method for the identification of hydroxyphenylpyruvate dioxygenase inhibitors
07/20/2005EP1554242A1 Watersoluble prodrugs of propofol
07/20/2005EP1554240A1 Substituted tetralins and indanes and their use
07/20/2005EP1553985A2 Biphenyls and fluorenes as imaging agents in alzheimer's disease
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005EP1185493B1 Quinones for treatment of diseases
07/20/2005EP1173408B1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
07/20/2005EP1066237B1 Processes for preparing intermediates
07/20/2005EP1056717B1 Arylphenyl-substituted cyclic keto-enols
07/20/2005CN1642906A Novel arylamidine derivative or salt thereof
07/20/2005CN1642902A Polyamine compounds and compositions for use in conjunction with cancer therapy
07/20/2005CN1642535A Tuberculosis treatment using pleuromutilin derivatives
07/20/2005CN1211360C Method for preparing methioylamine and methionine
07/20/2005CN1211359C New phenalkyoxy-phenyl derivatives
07/20/2005CN1211352C Cyclohexenone oxime ether metal salts
07/19/2005US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury
07/19/2005US6919380 Carbocyclic esters such as 5-chloro-2-methanesulfonylindan-1--yl-4-chlorobenzoate, used as anorexigenic agents; dietetics
07/19/2005US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
07/19/2005US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
07/19/2005US6919367 Substituted thioacetamides
07/19/2005US6919339 ABCA-1 elevating compounds
07/14/2005WO2005063780A1 Process for the preparation of pyridine derivatives
07/14/2005WO2005063729A1 3-(4-benzyloxyphenyl)propanoic acid derivatives
07/14/2005WO2005063689A1 Benzamide derivative
07/14/2005WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them
07/14/2005WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/14/2005US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance
07/14/2005US20050154230 Urea derivatives
07/14/2005US20050154062 Substituted chiral allosteric hemoglobin modifiers
07/14/2005US20050154061 peroxisome-proliferator-activated receptor (PPAR)-delta agonist; 2-[4-[[[2-[(2,4-Dichlorophenyl)amino]-2-oxoethyl]cyclohexylamino]methyl]-2-methylphenoxy]-2-methylpropanoic acid; cardiovascular disorders, dyslipidaemias or restenosis; improves HDL/LDL cholesterol ratio; side effect reduction
07/14/2005US20050154056 Inhibitors of HCV NS5B polymerase
07/14/2005US20050154011 such as S)-3-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester, used in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes
07/14/2005US20050153996 Compounds that modulate ppar activity and methods for their preparation
07/14/2005US20050153357 For detection of molecular interactions between immobilized ligands and receptors; immobilization on solid phase, biochemical conjugation, cleavage
07/14/2005US20050153291 Peptide/locked nucleic acid immobilization/synthesis
07/14/2005US20050153244 Sulfonate derivatives and the use thereof as latent acids
07/14/2005US20050153231 a mixture of photoinitiators, acyclic mercaptans, sensitizers and pigments, having high sensitivity and storage stability, used as photoresists for printing plates, color photography, solder, etching, color filter, holography, optical imaging and ultraviolet radiation inks or for forming precise patterns
07/14/2005DE10359668A1 Verfahren zur Herstellung von Methionin A process for producing methionine
07/14/2005CA2551610A1 3-(4-benzyloxyphenyl)propanoic acid derivatives
07/14/2005CA2550693A1 Process for the preparation of pyridine derivatives
07/13/2005EP1553078A1 Calcium receptor-active compounds
07/13/2005EP1552305A2 Polypeptide immobilization
07/13/2005EP1551791A1 Novel salt forms of poorly soluble probucol esters and ethers
07/13/2005EP1551654A1 A vehicle and a vehicle door
07/13/2005EP1161415B1 N-cyanomethylamides as protease inhibitors
07/13/2005CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
07/13/2005CN1639116A Phenolic compound and recording material containing the same
07/13/2005CN1639114A Malononitrile compounds and their use as pesticides
07/13/2005CN1637626A Organophotoreceptor with a charge transport material having at least three linked hydrazone groups
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636976A Mutilin derivatives and their use as antibacterials
07/13/2005CN1636975A Process for the preparation of methionine from hydrotrope of methionine alkali metal salt
07/13/2005CN1636457A Fungicides for the control of take-all disease of plants
07/13/2005CN1210270C Novel use of phenylheteroalkylamine derivatives
07/13/2005CN1210269C Preparation of 4-trioalkylbromobenzene derivatives
07/13/2005CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
07/13/2005CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds
07/12/2005US6916850 Pyruvate derivatives
07/12/2005US6916848 Compounds for the treatment of metabolic disorders
07/12/2005US6916835 Nitrate esters and their use for neurological conditions
07/07/2005WO2005061469A1 Method for producing chiral mercapto amino acids
07/07/2005WO2005061448A1 Compositions and methods for treating vascular conditions
07/07/2005WO2005061443A2 Benzoyl-substituted phenylalanine amides
07/07/2005WO2005061433A2 Aminoalcohol derivatives
07/07/2005WO2005060692A2 Biphenyl compounds and methods
07/07/2005WO2005049593A3 N-acylsulfonamide apoptosis promoters
07/07/2005WO2005042442A3 2-methylthio-1,4-naphthoquinone derivatives, methods for the production thereof, pharmaceutical compositions containing the same, and use thereof
07/07/2005WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/07/2005WO2005014524A3 Amino thiol compounds and compositions for use in conjunction with cancer therapy
07/07/2005WO2004098516A3 Cyclic derivatives as modulators of chemokine receptor activity
07/07/2005US20050148670 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines
07/07/2005US20050148656 Carboxylic derivates
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 272